El Pollo Loco Holdings, Inc. to Announce Fourth Quarter and Full Year 2023 Results on Thursday, March 7, 2024
COSTA MESA, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) — El Pollo Loco Holdings, Inc. (“El Pollo Loco”) (NASDAQ: LOCO) today […]
Sprout Social Announces Fourth Quarter 2023 Financial Results Above Guidance Range
CHICAGO, Feb. 20, 2024 (GLOBE NEWSWIRE) — Sprout Social, Inc. (“Sprout Social”, the “Company”) (Nasdaq: SPT), an industry-leading provider of […]
Dave to Report Fourth Quarter and Full Year 2023 Results on March 5, 2024 at 8:30 a.m. ET
LOS ANGELES, Feb. 20, 2024 (GLOBE NEWSWIRE) — Dave Inc. (“Dave” or the “Company”) (Nasdaq: DAVE), one of the nation’s […]
BigCommerce to Present at Morgan Stanley Technology, Media & Telecom Conference
AUSTIN, Texas, Feb. 20, 2024 (GLOBE NEWSWIRE) — BigCommerce Holdings, Inc. (“BigCommerce”) (Nasdaq: BIGC), a leading Open SaaS ecommerce platform […]
Noodles & Company to Announce Fourth Quarter and Full Year 2023 Results on March 7, 2024
BROOMFIELD, Colo., Feb. 20, 2024 (GLOBE NEWSWIRE) — Noodles & Company (NASDAQ: NDLS) today announced that it will host a […]
Adeia Announces Fourth Quarter And Full Year 2023 Financial Results
Signed 8 deals in the fourth quarter and 32 in 2023 across both media and semiconductor Paid down $29 million […]
Potbelly Corporation Announces Conference Call to Discuss Fourth Quarter and Full Year 2023 Results on March 7, 2024
CHICAGO, Feb. 20, 2024 (GLOBE NEWSWIRE) — Potbelly Corporation (NASDAQ: PBPB) (“Potbelly” or the “Company”), the iconic neighborhood sandwich shop […]
Olaplex Holdings, Inc. to Report Fourth Quarter and Fiscal 2023 Financial Results on February 29th
SANTA BARBARA, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) — Olaplex Holdings, Inc. (“OLAPLEX”), today announced that it plans to report […]
The Children’s Place Provides Shareholder Update
SECAUCUS, N.J., Feb. 15, 2024 (GLOBE NEWSWIRE) — The Children’s Place, Inc. (Nasdaq: PLCE), an omni-channel children’s specialty portfolio of […]
Alvotech Announces Expected Global Market Entry Dates for AVT04 Biosimilar to Stelara® (ustekinumab)
REYKJAVIK, Iceland, Feb. 15, 2024 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and […]
